Fund Holdings — Cormorant Asset Management, LP

Total Portfolio Value
$1.72B
Total Bought
$436.51M
Total Sold
$722.76M
Net Transaction
-$286.25M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
RAPPORT THERAPEUTICS INC(RAPP)02,940,283+2,940,283068,3913.98%+68,391
VAXCYTE INC(PCVX)685,0001,100,000+415,00046,79283,0614.83%+36,269
AXSOME THERAPEUTICS INC(AXSM)0400,000+400,000032,2001.87%+32,200
INSMED INC(INSM)575,000675,000+100,00015,60045,2252.63%+29,625
ALUMIS INC02,147,400+2,147,400028,5601.66%+28,560
UROGEN PHARMA LTD(URGN)01,650,000+1,650,000027,6871.61%+27,687
SAREPTA THERAPEUTICS INC(SRPT)0125,000+125,000019,7501.15%+19,750
CULLINAN THERAPEUTICS INC(CGEM)01,125,000+1,125,000019,6201.14%+19,620
Y-MABS THERAPEUTICS INC01,450,000+1,450,000017,5161.02%+17,516
MERUS N V715,000840,000+125,00032,19649,7032.89%+17,506
AVIDITY BIOSCIENCES INC0425,000+425,000017,3611.01%+17,361
JANUX THERAPEUTICS INC(JANX)750,0001,050,000+300,00028,23843,9852.56%+15,747
CORBUS PHARMACEUTICALS HLDGS(CRBP)2,025,0002,025,000079,46191,6315.33%+12,170
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
1,500,0002,300,000+800,00035,47544,1832.57%+8,708
CENTESSA PHARMACEUTICALS PLC561,6001,611,600+1,050,0006,34614,5530.85%+8,207
CRINETICS PHARMACEUTICALS IN(CRNX)1,150,0001,350,000+200,00053,83260,4673.52%+6,635
LONGBOARD PHARMACEUTICALS IN3,353,1412,790,462-562,67972,42875,4264.39%+2,998
ARCUTIS BIOTHERAPEUTICS INC(ARQT)2,125,0002,525,000+400,00021,05923,4831.37%+2,424
LANTHEUS HLDGS INC(LNTH)75,00075,00004,6686,0220.35%+1,354
GH RESEARCH PLC(GHRS)593,043593,04306,3226,9150.40%+593
ARRIVENT BIOPHARMA INC(AVBP)515,000515,00009,1989,5530.56%+355
STOKE THERAPEUTICS INC(STOK)427,163427,16305,7675,7710.34%+4
HELIX ACQUISITION CORP II2,909,0002,909,000030,25429,7301.73%-524
EDGEWISE THERAPEUTICS INC(EWTX)3,006,5343,006,534054,83954,1483.15%-692
VYNE THERAPEUTICS INC(YARW)1,394,3361,394,33604,2812,7470.16%-1,534
SILENCE THERAPEUTICS PLC(SLN)625,000625,000013,50011,8750.69%-1,625
ABIVAX SA(ABVX)2,130,0002,130,000030,45928,1591.64%-2,300
VERVE THERAPEUTICS INC350,000350,00004,6481,7080.10%-2,940
RAPT THERAPEUTICS INC496,750496,75004,4611,5150.09%-2,946
BIOATLA INC(BCAB)1,170,8700-1,170,8704,0280—-4,028
RHYTHM PHARMACEUTICALS INC(RYTM)550,000475,000-75,00023,83219,5041.13%-4,328
CG ONCOLOGY INC(CGON)800,000975,000+175,00035,12030,7811.79%-4,339
BIOHAVEN LTD(BHVN)616,963801,963+185,00033,74227,8361.62%-5,906
MERSANA THERAPEUTICS INC2,600,0002,600,000011,6485,2260.30%-6,422
CARGO THERAPEUTICS INC1,182,5631,182,563026,39519,4181.13%-6,977
ENGENE HOLDINGS INC
COM
1,000,0001,000,000016,9509,4300.55%-7,520
DISC MEDICINE INC(IRON)125,0000-125,0007,7830—-7,782
ROCKET PHARMACEUTICALS INC(RCKT)300,0000-300,0008,0820—-8,082
COMPASS THERAPEUTICS INC(CMPX)5,560,3002,030,823-3,529,47711,0092,0310.12%-8,979
SPYRE THERAPEUTICS INC(SYRE)250,0000-250,0009,4830—-9,482
IMMUNEERING CORP3,295,2730-3,295,2739,5230—-9,523
KYVERNA THERAPEUTICS INC(KYTX)440,0000-440,00010,9300—-10,930
IDEAYA BIOSCIENCES INC(IDYA)450,000245,000-205,00019,7468,6020.50%-11,144
PHARVARIS N V
COM
1,711,4601,466,460-245,00039,55227,5691.60%-11,982
NKARTA INC(NKTX)1,350,0000-1,350,00014,5940—-14,593
VENTYX BIOSCIENCES INC2,710,0000-2,710,00014,9050—-14,905
ASTRIA THERAPEUTICS INC1,300,0000-1,300,00018,2980—-18,297
CABALETTA BIO INC(CABA)1,100,0000-1,100,00018,7660—-18,766
APELLIS PHARMACEUTICALS INC
COM
400,0000-400,00023,5120—-23,512
NEUROGENE INC(NGNE)538,714107,344-431,37027,4213,9060.23%-23,514
TOURMALINE BIO INC1,250,0000-1,250,00028,6250—-28,625
MARINUS PHARMACEUTICALS INC3,250,0000-3,250,00029,3800—-29,380
AEROVATE THERAPEUTICS INC1,069,7960-1,069,79631,6340—-31,634
ALX ONCOLOGY HLDGS INC(ALXO)3,142,0790-3,142,07935,0340—-35,034
BIOMEA FUSION INC(BMEA)3,570,8723,570,872053,38516,0690.93%-37,316
KORRO BIO INC(KRRO)529,170265,826-263,34447,6259,0040.52%-38,622
ARCELLX INC
COMMON STOCK
1,780,0001,525,000-255,000123,79984,1654.90%-39,634
AUTOLUS THERAPEUTICS PLC(AUTL)6,616,6670-6,616,66742,2140—-42,214
PRAXIS PRECISION MEDICINES I(PRAX)1,310,000685,000-625,00079,93628,3321.65%-51,605
BRIDGEBIO PHARMA INC(BBIO)3,203,0291,858,351-1,344,67899,03847,0722.74%-51,966
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)8,494,1518,494,1510426,661373,48821.72%-53,173
TARSUS PHARMACEUTICALS INC(TARS)2,139,102500,000-1,639,10277,75613,5900.79%-64,166
EYEPOINT PHARMACEUTICALS INC(EYPT)6,893,2358,325,000+1,431,765142,48372,4284.21%-70,056
ALPINE IMMUNE SCIENCES INC2,700,0000-2,700,000107,0280—-107,028
Page 1 of 1
Cormorant Asset Management, LP — 13F Holdings — Q2 2024 | TickerTrail